2-amino-5-chlorobenzaldehyde - CAS 20028-53-9
Catalog: |
BB015460 |
Product Name: |
2-amino-5-chlorobenzaldehyde |
CAS: |
20028-53-9 |
Synonyms: |
2-amino-5-chlorobenzaldehyde; 2-amino-5-chlorobenzaldehyde |
IUPAC Name: | 2-amino-5-chlorobenzaldehyde |
Description: | 2-amino-5-chlorobenzaldehyde (CAS# 20028-53-9) is an intermediate used in the synthesis of 6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine (C381440), which is an impurity of Etoricoxib (E934100), a specific inhibitor of COX-2. |
Molecular Weight: | 155.58 |
Molecular Formula: | C7H6ClNO |
Canonical SMILES: | C1=CC(=C(C=C1Cl)C=O)N |
InChI: | InChI=1S/C7H6ClNO/c8-6-1-2-7(9)5(3-6)4-10/h1-4H,9H2 |
InChI Key: | KUIFMGITZFDQMP-UHFFFAOYSA-N |
Boiling Point: | 288.1 °C at 760 mmHg |
Melting Point: | 71-73 °C |
Purity: | 99 % |
Density: | 1.348 g/cm3 |
MDL: | MFCD02093936 |
LogP: | 2.31590 |
GHS Hazard Statement: | H315 (66.67%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (66.67%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (33.33%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020223717-A1 | Process for preparation of aldehyde scavenger and intermediates | 20190502 |
WO-2020205921-A1 | Hck inhibitors for the treatment of fibrosis and cancer | 20190402 |
WO-2019051396-A1 | SMALL MOLECULE INHIBITORS OF EBOLA VIRUSES AND LASSA FEVER, AND METHODS OF USE THEREOF | 20170908 |
US-2021163454-A1 | Small molecule inhibitors of ebola and lassa fever viruses and methods of use | 20170908 |
CN-107522766-B | Ursolic acid quinolyl hydrazide derivatives with anti-tumor activity and preparation method and application thereof | 20170821 |
PMID | Publication Date | Title | Journal |
21126022 | 20110113 | Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase | Journal of medicinal chemistry |
Complexity: | 129 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 155.0137915 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 155.0137915 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 43.1 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS